# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-24-001124
Filing Date
2024-03-28
Accepted
2024-03-28 06:03:18
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | zk2431185.htm iXBRL | 20-F | 2489148
2 | EXHIBIT 2.1 | exhibit_2-1.htm | EX-2.1 | 119108
3 | EXHIBIT 12.1 | exhibit_12-1.htm | EX-12.1 | 8686
4 | EXHIBIT 12.2 | exhibit_12-2.htm | EX-12.2 | 9268
5 | EXHIBIT 13.1 | exhibit_13-1.htm | EX-13.1 | 5078
6 | EXHIBIT 13.2 | exhibit_13-2.htm | EX-13.2 | 5202
7 | EXHIBIT 15.1 | exhibit_15-1.htm | EX-15.1 | 3427
8 | EXHIBIT 97.1 | exhibit_97-1.htm | EX-97.1 | 39039
9 | GRAPHIC | cmmb_img01.jpg | GRAPHIC | 205258
10 | GRAPHIC | cmmb_img02.jpg | GRAPHIC | 2732
16 | GRAPHIC | image00034.jpg | GRAPHIC | 33267
17 | GRAPHIC | image3.jpg | GRAPHIC | 176360
18 | GRAPHIC | image13.jpg | GRAPHIC | 585300
19 | GRAPHIC | image00024.jpg | GRAPHIC | 26932
20 | GRAPHIC | image00025.jpg | GRAPHIC | 31599
21 | GRAPHIC | image00026.jpg | GRAPHIC | 18221
22 | GRAPHIC | image00027.jpg | GRAPHIC | 33968
23 | GRAPHIC | image00028.jpg | GRAPHIC | 18453
24 | GRAPHIC | image00029.jpg | GRAPHIC | 19370
25 | GRAPHIC | image00030.jpg | GRAPHIC | 28006
26 | GRAPHIC | image00031.jpg | GRAPHIC | 37685
27 | GRAPHIC | image00032.jpg | GRAPHIC | 13409
28 | GRAPHIC | image00033.jpg | GRAPHIC | 46938
29 | GRAPHIC | image00019.jpg | GRAPHIC | 37572
30 | GRAPHIC | image00020.jpg | GRAPHIC | 41093
31 | GRAPHIC | image00021.jpg | GRAPHIC | 29840
32 | GRAPHIC | image00022.jpg | GRAPHIC | 33408
33 | GRAPHIC | image00023.jpg | GRAPHIC | 63582
| Complete submission text file | 0001178913-24-001124.txt |  | 12124889

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL SCHEMA FILE | cmmb-20231231.xsd | EX-101.SCH | 56634
12 | XBRL CALCULATION FILE | cmmb-20231231_cal.xml | EX-101.CAL | 48011
13 | XBRL DEFINITION FILE | cmmb-20231231_def.xml | EX-101.DEF | 130646
14 | XBRL LABEL FILE | cmmb-20231231_lab.xml | EX-101.LAB | 507277
15 | XBRL PRESENTATION FILE | cmmb-20231231_pre.xml | EX-101.PRE | 267538
101 | EXTRACTED XBRL INSTANCE DOCUMENT | zk2431185_htm.xml | XML | 1286055

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38807 | Film No.: 24793250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)